Faculty

Department Leadership

Homer A. Macapinlac, M.D. - Professor, James E. Anderson Distinguished Professor of Nuclear Medicine, Chair, Department of Nuclear Medicine

Research Interests: Early response evaluation in solid tumors (e.g. lung cancer, lymphoma) using various novel PET tracers in comparison to FDG. Novel theranostic multi-tracer techniques using PET/CT or SPECT/CT for pre-therapy dosimetry/patient selection, alpha/beta therapy and post therapy dose estimates in patients with prostate, neuroendocrine and breast cancer. Novel PET/MR techniques to improve multi-parametric image quantification in early recurrence of prostate cancer.

Yang Lu, M.D., Ph.D. - Associate Professor, Medical Director of Clinical Nuclear Medicine, Department of Nuclear Medicine

Research Interests: Radiomics studies to promote patient care, novel radiotracers and radiopharmaceuticals for molecular imaging and targeted therapy.

Gregory C. Ravizzini, M.D. - Associate Professor, ad interim CABI Medical Director

Research Interests: Pre-clinical and clinical molecular imaging for oncological applications, the development of novel radiopharmaceuticals for imaging and targeted radiotherapy.

Faculty

Beth A. Chasen, M.D. - Associate Professor

Research Interests: Radiopharmaceuticals as diagnostic and therapeutic agents; novel radiotracer use in clinical operations, image acquisition, and interpretation.

Hubert H. Chuang, M.D., Ph.D. - Associate Professor

Research Interests: PET/CT in patients with Lymphoma, PET/CT imaging response prediction for paraganglioma/pheochromocytoma, plasmacytoma, adrenocortical carcinoma (ACC), malignancy of unknown origin and bone and soft tissue tumors.

Lesley Flynt, M.D. - Assistant Professor

Research Interests: The role of therapy nuclear medicine combined with diagnostic imaging, as applied to the development and application of novel theranostic agents. The implications of metabolic tumor volume on doubling time and prognosis in patients with solid tumors.

Elmer B. Santos, M.D., Ph.D. - Assistant Professor

Research Interests: Development and clinical application of new radiotracers and radiotherapies for thyroid, prostate, and neuroendocrine tumors: Clinical use of radioactive anti-human kallikrein 2 antibody for diagnosis and therapy of primary and metastatic prostate cancer; Restoring radioiodine responsiveness by inhibiting Ras/Raf/MEK pathway in RAI-refractory thyroid cancer; Clinical utility of 68Ga-DOTATOC in detecting neuroendocrine tumors.

Devaki Shilpa Surasi, M.B.B.S - Assistant Professor

Research Interests: Health services and comparative effectiveness research and quality improvement.

Franklin C. Wong, M.D., Ph.D., JD, MS, MBA - Professor

Research Interests: Animal tumor model.

Guofan Xu, M.B.B.S., Ph.D. - Assistant Professor

Research Interests: Development of multi-modal imaging techniques with pre-clinical and clinical molecular tracers for oncological imaging and targeted radiotherapy.